MARBOCYL PALATABLE 80MG 6 TABLETS | ANTIBACTERIAL FOR DOGS

MARBOCYL

Interactions and incompatibilities
• Fluoroquinolones are known to interact with orally administered cations (aluminum, calcium, magnesium, iron). In such cases, bioavailability may be reduced.
• Theophylline dose should be reduced when used concurrently.
• Administer with caution when used in conjunction with non-steroidal anti-inflammatory drugs.

Indications and target species
Dogs: Marbofloxacin tablets are indicated for the treatment of:
– Skin infections (intertrigo, folliculitis, impetigo, furunculosis) caused by sensitive strains.
– Soft tissue infections caused by susceptible strains.
– Upper and lower urinary tract infections, associated or not with prostatitis or epididymitis, caused by susceptible strains.
– Respiratory tract infections caused by susceptible strains.
Contraindications
• Although studies have shown that administration of marbofloxacin to growing medium-sized beagle dogs at doses up to 6 mg/kg/day for 13 weeks did not show signs of articular cartilage toxicity, it should not be used. this product on puppies
of large breeds.
• Do not administer to epileptic animals in the absence of data in these cases.
• Contraindicated during the gestation and lactation periods.
efectos secundarios
• At the recommended therapeutic dose no serious adverse reactions are expected in dogs.
• Occasionally mild adverse reactions such as vomiting, diarrhea, polydipsia, polyuria and hyperactivity may appear. These signs cease spontaneously after treatment and do not require its discontinuation.
• Due to the release of histamine that it could produce, the appearance of symptoms of allergic processes has been described, which are mild and transient skin reactions (severe hypotension is not observed).
• On rare occasions, nervous symptoms (ataxia, agitation, aggressiveness, convulsions and prostration) and joint pain may appear.
Route of administration
Orally.
Posology
The recommended dose is 2 mg/kg/day (1 tablet per 40 kg per day) in a single daily administration.
• In skin and soft tissue infections, the duration of treatment is a minimum of 5 days. Depending on the clinical evolution, it can last up to 40 days.
• In the case of superficial and severe pyoderma, an initial duration of treatment of 10 to 20 days respectively is recommended, with a maximum duration of up to 40 days that will be established based on the clinical evolution of the process.
• In lower urinary tract infections, the duration of treatment is a minimum of 10 days. In case of associated prostatitis or epididymitis, or in case of upper urinary tract infections, treatment can be extended up to 28 days.
• In the case of respiratory infections, the duration of treatment is at least 7 days, and can be extended up to 21 depending on the clinical evolution of the process.
overdose: The characteristic symptoms that may appear are salivation and vomiting, weight loss and decreased activity.
Reduced weight of the thymus has also been reported in dogs for 14 days and with the dose
highest tested (100 mg/kg) Only very high doses (≥2000 mg/kg), hardly achievable with tablets, can cause
acute signs in the form of neurological disorders, which would be treated symptomatically.
Special precautions
None.
Wait time
Not applicable.
Comments
With veterinary prescription.
Presentation
Packages of 6 tablets (1 blister pack of 6 tablets) and 72 tablets (12 blister packs of 6
tablets and dosing sachets)
Reg No.
1641 ESP

See technical sheet

See technical sheet

Marbocyl